The role of expressed emotions indicator as a predictor of the course of schizophrenia
Journal Title: Psychiatria Polska - Year 2010, Vol 44, Issue 2
Abstract
Objective. The study is a part of a prospective schizophrenia research project run in Kraków. The general objective of the project is a long-time observation of people with schizophrenia, starting from the first episode through the years of living with the illness, the assessment of treatment results and predictors. The goal of this study was to investigate whether the level of expressed emotions in family at the onset of schizophrenia may have a prognostic value in regard to the further course of the illness. Method. Four indicators of treatment results were observed: the number of relapses, the overall time of inpatient hospitalisations, the number of inpatient hospitalisations and the severity of psychopathological symptoms, all in 3, 7 and 12 years since first hospitalisations. Expressed emotions (EE) were assessed with Camberwell Family Interview (CFI), the severity of symptoms was assessed with BPRS-SA, the UCLA version. Results. 1) The increase of the number of relapses in subsequent follow-ups was more pronounced in the group of subjects with higher EE at the time of their first hospitalisations. 2) The number and overall time of hospitalisations did not correspond in any way with the EE level at the time of the first hospitalisation. 3) The dynamics of general and positive symptoms was related to the EE level at the time of the first hospitalisation. The negative syndrome was found to have no significant relationships. Conclusions. 1) The level of EE at the time of the first hospitalisation can be regarded as a specific predictor of relapses in the study group. 2) Creating research models that enable to differentiate: trait and state as well as dependent on family and on the course of illness aspects of EE, would enable better understanding of this phenomenon, which appears both as predictor and as effect of the course of schizophrenia.
Authors and Affiliations
Andrzej Cechnicki, Igor Hanuszkiewicz, Roman Polczyk, Łukasz Cichocki, Aneta Kalisz, Maria Rostworowska
Keywords
Related Articles
- EP ID EP113352
- DOI -
- Views 93
- Downloads 0
TMS in therapy of depressions - the problem of determining the area to be stimulated, i.e., a few words about the anatomy of depressive disorders
Since 1992 transcranial magnetic stimulation TMS is studied on its antidepressant efficacy. Clinical investigations show, that active stimulation is indeed more effective than placebo; the antidepressant effect itself is...
Nowe role osób chorujących psychicznie w procesie leczenia i zdrowienia
W wielu krajach wzrasta świadomość znaczenia pomocy świadczonej sobie wzajemnie przez pacjentów chorujących psychicznie. To działanie przynosi korzyść w postaci większej aktywności, samodzielności, umacnia i przywraca po...
Wenlafaksyna i sertralina nie wpływają na ekspresję genów regulujących poziom kortyzolu u kobiet chorych na depresję
Cel pracy Celem pracy była analiza ekspresji trzech genów związanych z regulacją osi podwzgórze-przysadka-nadnercza (PPN): GR, HSP90 i FKBP5 u pacjentów z rozpoznaniem depresji w przebiegu choroby afektywnej jednobieguno...
Związek oceny relacji rodzinnych z depresją u dziewcząt z różnymi typami zaburzeń odżywiania się
Cel. Celem badania była ocena związku objawów depresyjnych z obrazem relacji rodzinnych w grupie pacjentek z rozpoznaniem różnych typów zaburzeń odżywiania się w porównaniu z pacjentkami z rozpoznaniem zaburzeń depresyjn...
ANKK1 gene in psychiatry
Summary According to last findings, one of the most commonly studied polymorphisms in psychiatry- Taq1A is located in the ANNK1(Ankyrin Repeat and Kinase Domain containing 1) gene, not in the dopamine receptor 2 (DRD2...